Nasus Pharma Ltd. ("Nasus Pharma" or the "Company"), a clinical-stage biopharmaceutical company focused on developing ...

Stocking unassigned epinephrine appears to be the most cost-effective strategy for treating anaphylaxis at summer camps, ...

Learn all about anaphylaxis, its symptoms, causes, and treatment. Recognise signs early and act quickly to manage this severe ...

Kaléo's epinephrine auto-injector is associated with lower rates of anaphylaxis-related inpatient hospitalizations compared to other epinephrine auto-injectors Richmond, Virginia, May 15 ...

neffy contains epinephrine, a medicine used to treat allergic emergencies (anaphylaxis). Anaphylaxis can be life-threatening, can happen in minutes, and can be caused by stinging and biting ...

INDICATION AND IMPORTANT SAFETY INFORMATION FOR neffy (epinephrine nasal spray) INDICATIONneffy is indicated for emergency treatment of type I allergic reactions, including anaphylaxis ...

Taking effect on July 1, 2025, the legislation requires all Florida K-8 public schools to be prepared to administer emergency ...

Other Epinephrine Auto-Injector Prescription Was Associated with Reduced Inpatient Hospitalizations for Anaphylaxis in a US Retrospective Commercial Claims Analysis" Wednesday, May 14th during the ...

Orexo AB (publ.), (STO: ORX) , announces the company will attend the 2025 EAACI Congress in Glasgow, UK, on June 13-16. The European Academy of Allergy and Clinical Immunology (EAACI) is a leading ...

"The expanded availability of neffy represents real progress for our community, especially for young children who may be more likely to speak up about symptoms of a serious allergic reaction when they ...